Bioscript Group
Dominik Hoelper is an experienced regulatory and medical writer currently working at Bioscript Group since June 2023. Prior to this role, Dominik served as a Medical Writer 1 at IQVIA from March 2021 to June 2023, where responsibilities included leading the preparation of regulatory documents and providing writing support for clinical research manuscripts. Dominik's academic journey includes a postdoctoral researcher position at The University of Edinburgh, focusing on CRISPR/dCas9 technology, and a doctoral research role at the University of Wisconsin-Madison, investigating chromatin-associated proteins in cancer. Dominik holds a Ph.D. in Biochemistry from the University of Wisconsin-Madison, an M.Sc. in Life and Medical Sciences, and a B.Sc. in Molecular Biomedicine, all from the University of Bonn.
This person is not in the org chart
This person is not in any teams
Bioscript Group
Established in 2005, Bioscript Group is formed from multiple, specialist businesses to support our global pharmaceutical clients; we draw on their multidisciplinary expertise to help navigate critical decisions at key points in the product lifecycle. Our scientific and strategic expertise help our clients make better decisions. We provide medical communication services, market access consulting and regulatory writing support with deep domain expertise to effectively navigate complex disease areas.